FGF-19 analogues for the treatment of metabolic dysfunction-associated steatohepatitis: a systematic review and meta-analysis

被引:0
|
作者
Khalil, Samira Mohamad [1 ]
Souza, Matheus [2 ]
de Oliveira, Fabiana Dolovitsch [3 ]
Buarque de Santana Sato, Emmily Daiane [4 ]
Meine, Gilmara Coelho [5 ]
机构
[1] Univ Buenos Aires, Buenos Aires, DF, Argentina
[2] Univ Fed Rio De Janeiro, Rio De Janeiro, Brazil
[3] Univ Fed Ciencias Saude Porto Alegre, Porto Alegre, RS, Brazil
[4] Pontificia Univ Catolica Campinas, Campinas, Brazil
[5] Univ Feevale, Novo Hamburgo, Brazil
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
SAT-244
引用
收藏
页码:S618 / S619
页数:2
相关论文
共 50 条
  • [1] Efficacy and safety of FGF21 analogues in the treatment of metabolic dysfunction-associated steatohepatitis: an updated systematic review and meta-analysis
    de Oliveira, Fabiana Dolovitsch
    Buarque de Santana Sato, Emmily Daiane
    Khalil, Samira Mohamad
    Souza, Matheus
    Meine, Gilmara Coelho
    JOURNAL OF HEPATOLOGY, 2024, 80 : S616 - S617
  • [2] Efficacy and safety of aldafermin for the treatment of metabolic dysfunction-associated steatohepatitis: A systematic review and meta-analysis
    Khalil, Samira Mohamad
    de Souza, Matheus Henrique Gonsalves
    de Oliveira, Fabiana Dolovitsch
    Sato, Emmily Daiane Buarque de Santana
    Meine, Gilmara Coelho
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2025, 49 (05)
  • [3] Efficacy and Safety of Fibroblast Growth Factor 21 Analogues for Metabolic Dysfunction-Associated Steatohepatitis: A Systematic Review and Meta-Analysis
    de Oliveira, Fabiana Dolovitsch
    Khalil, Samira Mohamad
    Sato, Emmily Daiane Buarque de Santana
    de Souza, Matheus Henrique Goncalves
    Meine, Gilmara Coelho
    ANNALS OF NUTRITION AND METABOLISM, 2025, 81 (01) : 51 - 60
  • [4] Effect of bariatric surgery on circulating FGF-19: A systematic review and meta-analysis
    Ryan, Paul M.
    Hayward, Nathaniel E.
    Sless, Ryan T.
    Garwood, Philip
    Rahmani, Jamal
    OBESITY REVIEWS, 2020, 21 (08)
  • [5] Efficacy and Safety of Fibroblast Growth Factor-21 Analogs for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis: A Systematic Review and Meta-Analysis
    Jeong, Changhyeon
    Han, Nayoung
    Jeon, Nakyung
    Rhee, Su-jin
    Staatz, Christine E.
    Kim, Min-Soo
    Baek, In-hwan
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (01) : 72 - 81
  • [6] EFFICACY AND ADVERSE EVENTS OF RESMETIROM 80 MG IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH): A SYSTEMATIC REVIEW AND META-ANALYSIS
    Nekkanti, Ankita
    Vohra, Ishaan
    Gopakumar, Harishankar
    Dhillon, Sonu
    Sharma, Neil
    Puli, Srinivas
    HEPATOLOGY, 2024, 80
  • [7] Comment on "Effect of bariatric surgery on circulating FGF-19: A systematic review and meta-analysis"
    Babajafari, Siavash
    Shafiee, Maryam
    Dianatinasab, Mostafa
    Mazloomi, Seyed Mohammad
    OBESITY REVIEWS, 2021, 22 (09)
  • [8] Correspondence to letter to the editor on "Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis"
    Cho, Yuri
    Jun, Dae Won
    CLINICAL AND MOLECULAR HEPATOLOGY, 2025, 31 (01)
  • [9] Comparison of pharmacological therapies in metabolic dysfunction-associated steatohepatitis for fibrosis regression and MASH resolution: Systematic review and network meta-analysis
    Souza, Matheus
    Al-Sharif, Lubna
    Antunes, Vanio L. J.
    Huang, Daniel Q.
    Loomba, Rohit
    HEPATOLOGY, 2025,
  • [10] Effect on lipid profile and clinical outcomes of obeticholic acid for the treatment of primary biliary cholangitis and metabolic dysfunction-associated steatohepatitis: A systematic review and meta-analysis
    Jang, Hyejung
    Han, Nayoung
    Staatz, Christine E.
    Kwak, Jae-Hwan
    Baek, In-hwan
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2023, 47 (10)